ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

MYMD MyMD Pharmaceuticals Inc

2.35
0.16 (7.31%)
18 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
MyMD Pharmaceuticals Inc MYMD 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.16 7.31% 2.35 09:00:00
개장가 저가 고가 종가 전일 종가
2.20 2.20 2.363 2.35 2.19
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
17/05/202406:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/05/202406:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/03/202406:30EDGAR2Form 8-K - Current report
06/03/202401:00EDGAR2Form 8-K - Current report
05/03/202423:15BWMyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum..
15/02/202405:13EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/02/202401:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202406:57EDGAR2Form 8-K - Current report
14/02/202401:45BWMyMD Pharmaceuticals Announces Reverse Stock Split to..
06/12/202323:15EDGAR2Form 8-K - Current report
06/12/202323:15BWMyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical..
19/10/202322:00EDGAR2Form 8-K - Current report
19/10/202322:00BWMyMD Announces Preclinical Study Results Showing Novel..
14/10/202306:00EDGAR2Form 8-K - Current report
05/10/202305:30EDGAR2Form 8-K - Current report
04/10/202320:30BWMyMD Pharmaceuticals to Present Updated Statistically..
09/09/202306:24EDGAR2Form 8-K - Current report
25/08/202306:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/08/202305:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/08/202306:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/08/202321:30EDGAR2Form 8-K - Current report
14/08/202321:30BWFDA Accepts MyMD Pharmaceuticals’ Investigational New Drug..
04/08/202305:30EDGAR2Form 8-K - Current report
02/08/202321:30BWMyMD Pharmaceuticals to Hold Conference Call Today to..
02/08/202305:30EDGAR2Form 8-K - Current report
31/07/202322:00EDGAR2Form 8-K - Current report
31/07/202322:00BWMyMD Pharmaceuticals Reports Statistically Significant..
22/07/202305:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/07/202321:30EDGAR2Form 8-K - Current report
01/07/202305:30EDGAR2Form DEF 14A - Other definitive proxy statements